GABPA and glioblastoma: The ETS family member GABPB1, required for the TERT transcription in TERT promoter-bearing glioblastoma cells, has been proposed as a target for glioblastoma treatment [56], but our results showed that inhibiting GABPA or GABPB1 robustly increased invasiveness of TC cells despite significant downregulation of TERT expression [59].